Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 7.18 | 24.01 |
PEG Ratio (TTM) | 0.42 | -0.37 |
P/S Ratio (TTM) | 0.70 | 3.12 |
P/B Ratio (TTM) | 1.60 | 1.71 |
P/FCF Ratio (TTM) | 14.61 | 37.58 |
Price to 5YR AVG Earnings Ratio | 29.88 | 41.37 |
Price to 5YR AVG FCF Ratio | -60.96 | 46.02 |
Profitability (45%) |
Company | Industry |
---|---|---|
ROA (TTM) | 9.61% | 11.09% |
ROE (TTM) | 23.84% | -9.97% |
Net Profit Margin (TTM) | 9.70% | 12.54% |
ROIC 5YR AVG | 4.13% | 22.38% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 120.77% | 211.87% | 142.05% |
Revenue | 3.17% | 9.64% | 7.50% |
Net Income | 120.08% | 213.87% | 143.16% |
Cash Flow | 410.21% | -591.27% | -87.00% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.78 | 1.60 |
Quick Ratio (TTM) | 1.50 | 1.10 |
D/E Ratio (TTM) | 0.26 | -0.33 |
Interest Coverage (TTM) | 8.62 | 13.84 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 2.58 | 5.33 |
LTL to 5YR AVG FCF | -12.33 | 6.07 |
Shares Outstanding Growth 5YR AVG | 0.43% | -0.67% |